Trevi Therapeutics, Inc. (TRVI) Q2 2024 Earnings
TRVI·Reported August 8, 2024·After market close
Diluted EPS came in at $-0.12, missed the $-0.11 consensus by $0.01.
Diluted EPS
$-0.12missed by $0.01
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Trevi Therapeutics, Inc.'s Q2 2024 earnings report.
Trevi Therapeutics, Inc. (TRVI) reported Q2 2024 earnings on August 8, 2024 after market close.
Trevi Therapeutics, Inc. reported diluted EPS of $-0.12 for Q2 2024.
EPS missed the consensus estimate of $-0.11 by $0.01.
You can read the 10-Q periodic report (0000950170-24-093983) directly on SEC EDGAR. The filing index links above go to sec.gov.